doi: 10.1126/science.336.6083.792.
AIDS research. FDA panel recommends anti-HIV drug for prevention
- PMID: 22605725
- DOI: 10.1126/science.336.6083.792
Item in Clipboard
AIDS research. FDA panel recommends anti-HIV drug for prevention
Science.
.
No abstract available
Similar articles
-
HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.Science. 2010 Dec 3;330(6009):1298-9. doi: 10.1126/science.330.6009.1298. Science. 2010. PMID: 21127220 No abstract available.
-
FDA approves first drug to prevent HIV infection.BMJ. 2012 Jul 17;345:e4879. doi: 10.1136/bmj.e4879. BMJ. 2012. PMID: 22807165 No abstract available.
-
HIV pre-exposure prophylaxis.BMJ. 2012 Aug 13;345:e5412. doi: 10.1136/bmj.e5412. BMJ. 2012. PMID: 22890030 No abstract available.
-
Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa. Nurse Pract. 2014. PMID: 25140852 Review.
-
Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.Am Fam Physician. 2013 Oct 15;88(8):535-40. Am Fam Physician. 2013. PMID: 24364575 Review. No abstract available.
Cited by
-
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.PLoS One. 2012;7(7):e40382. doi: 10.1371/journal.pone.0040382. Epub 2012 Jul 11. PLoS One. 2012. PMID: 22808148 Free PMC article.
-
Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.J Control Release. 2020 May 10;321:84-99. doi: 10.1016/j.jconrel.2020.02.006. Epub 2020 Feb 5. J Control Release. 2020. PMID: 32035194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
